
L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma
Author(s) -
Jussuf T. Kaifi,
Ulrich Zinnkann,
Emre F. Yekebas,
Paulus Schurr,
Uta Reichelt,
Robin Wachowiak,
Henning C. Fiegel,
Susann Petri,
Melitta Schachner,
Jakob R. Izbicki
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i1.94
Subject(s) - neuroendocrine tumors , pancreas , immunohistochemistry , pathology , neuroendocrine differentiation , medicine , carcinoma , cancer , prostate cancer
To determine the expression of L1 in pancreatic neuroendocrine tumor and to correlate it with WHO classification of this tumor.